The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said on Friday. India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 … Read more
Serum Institute of India (SII), on October 25, had applied to the Drugs Controller General of India (DCGI) seeking regular market authorization for the vaccine. Over 100 crore Covishield doses have been given in India and abroad which is a testimony of its safety and efficacy, Serum Institute has informed the DCGI which had sought … Read more
Adar Poonawalla, chief executive officer, SII, tweeted on Friday and said the company had supplied 1.25 billion doses of Covishield in India and the government had enough data for this permission. Serum Institute of India (SII) has sought full approval for its Covid-19 vaccine, Covishield. SII has applied to the ministry of health and family … Read more
The country has administered 114.78 crore vaccines of the Covishield vaccines till date. SII has exported seven crore doses of the Covishield. Serum Institute of India (SII) is planning to cut monthly production of Covishield by 50%, if it does not receive any fresh orders either from the government or from export markets. Adar Poonawalla, … Read more
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot through the COVAX network, the Indian government said on Wednesday. The world’s biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last week. Indonesia has approved … Read more
SII had reached this milestone ahead of time via rapid expansion of production capacity at its site in Pune, the company said. Serum Institute of India (SII) on Friday resumed exports to the international vaccine sharing programme COVAX. The first batches of its Covishield Covid-19 vaccine left the SII manufacturing facility in Pune for distribution … Read more
Singapore has established VTLs with two jurisdictions as of now, Germany and Brunei Darussalam (Reuters Photo) Vaccinated Travel Lane: International travel was no longer an easy affair after covid-19 hit the world. Countries across the world experimented and came up with various concepts to ensure passenger’s safe movement and travel between different nations. Some of … Read more
The CII partnership with SII will catalyse industry participation to reach out to communities at large. CII will connect the community, hospitals and corporates to fast-track vaccination Narendran said. The Confederation of Indian Industry (CII) has entered into an agreement with vaccine maker Serum Institute of India (SII) to take Covid-19 vaccines to small towns … Read more
“The vaccine has great potential to protect our future generations below the age of 18,” Poonawalla said. Serum Institute of India (SII) has started manufacturing the first batch of the Covovax Covid-19 vaccine from Friday at its Manjari facility in Pune. Covovax has been developed by US biotech company Novavax. SII has a collaboration with … Read more
Now there are 82,725 active cases, down from 83,809 the previous day and 49,974 of them are in home isolation, it said. To boost production of COVID-19 vaccine, the United States is looking at joint production of Johnson and Johnson’s vaccine in India and ways to help manufacturers such as India’s Serum Institute, Charge d’Affaires … Read more